Browse Subject Areas

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Row for Your Life: A Century of Mortality Follow-Up of French Olympic Rowers

  • Juliana Antero-Jacquemin ,

    Affiliations Institut de Recherche bioMédicale et d'Epidemiologie du Sport (IRMES), Institut National du Sport de l'Expertise et de la Performance (INSEP), Paris, France, Université Paris Descartes, EA 7329, Sorbonne Paris Cité, Paris, France

  • François Deni Desgorces,

    Affiliations Institut de Recherche bioMédicale et d'Epidemiologie du Sport (IRMES), Institut National du Sport de l'Expertise et de la Performance (INSEP), Paris, France, Université Paris Descartes, EA 7329, Sorbonne Paris Cité, Paris, France

  • Frédéric Dor,

    Affiliation Institut de Recherche bioMédicale et d'Epidemiologie du Sport (IRMES), Institut National du Sport de l'Expertise et de la Performance (INSEP), Paris, France

  • Adrien Sedeaud,

    Affiliation Institut de Recherche bioMédicale et d'Epidemiologie du Sport (IRMES), Institut National du Sport de l'Expertise et de la Performance (INSEP), Paris, France

  • Amal Haïda,

    Affiliation Institut de Recherche bioMédicale et d'Epidemiologie du Sport (IRMES), Institut National du Sport de l'Expertise et de la Performance (INSEP), Paris, France

  • Philippe LeVan,

    Affiliations Comité National Olympique et Sportif Français (CNOSF), Medical Commission, Paris, France, Institut National du Sport de l'Expertise et de la Performance (INSEP), Medical Department, Paris, France

  • Jean-François Toussaint

    Affiliations Institut de Recherche bioMédicale et d'Epidemiologie du Sport (IRMES), Institut National du Sport de l'Expertise et de la Performance (INSEP), Paris, France, Université Paris Descartes, EA 7329, Sorbonne Paris Cité, Paris, France, Centre d'Investigations en Médecine du Sport, Hôpital Hôtel-Dieu, Assistance Publique-Hôpitaux de Paris, Paris, France

Row for Your Life: A Century of Mortality Follow-Up of French Olympic Rowers

  • Juliana Antero-Jacquemin, 
  • François Deni Desgorces, 
  • Frédéric Dor, 
  • Adrien Sedeaud, 
  • Amal Haïda, 
  • Philippe LeVan, 
  • Jean-François Toussaint



Strenuous endurance training required to participate in the highest sports level has been associated with deleterious effects on elite athletes' health and cardiac abnormalities. We aimed to describe overall mortality and main causes of deaths of male French rowers participating in at least one Olympic Game (OG) from 1912 to 2012 in comparison with the French general population.


Identity information and vital status of French Olympic rowers were validated by National sources from 1912 to 2013 (study's endpoint) among 203 rowers; 52 out of 255 (20.3%) were excluded because their vital statuses could not be confirmed. Main causes of deaths were obtained from the National registry from 1968 up to 2012. Overall and disease-specific mortalities were calculated through standardised mortality ratios (SMRs) with its 95% confidence intervals (CIs). The overall mortality was calculated for the whole rowers' cohort (PT) and for two periods apart: (P1) including rowers from 1912 to 1936 OG, a cohort in which all rowers have deceased and (P2) considering rowers from 1948 to 2012 OG.


Among the 203 rowers analysed, 46 died before the study's endpoint, mainly from neoplasms (33%), cardiovascular diseases (21%) and external causes (18%). PT demonstrates a significant 42% lower overall mortality (SMR: 0.58, 95% CI: 0.43–0.78, p<0.001), P1 a 37% reduction (SMR: 0.63, 95% CI: 0.43–0.89, p = 0.009) and P2 a 60% reduction (SMR: 0.40, 95% CI: 0.23–0.65, p<0.001) compared with their compatriots. Mortality due to cardiovascular diseases is significantly reduced (SMR: 0.41, 95% CI: 0.16–0.84, p = 0.01) among rowers.


French Olympic rowers benefit of lower overall mortality compared with the French general population. Among rowers' main causes of death, cardiovascular diseases are reduced in relation to their compatriots. Analytical studies with larger samples are needed to understand the reasons for such reductions.


Rowing has been reported as a safe contactless sport with low injury rate, providing health benefits to its practitioners [1], [2]. Although high occurrence of cardiac diseases, and alterations on cardiovascular morphology has been previously reported in university rowers [3], [4], epidemiological studies have described higher life expectancy in Harvard and Yale university rowers as in Oxford-Cambridge boat racers compared with their non-athletic referents [5], [6].

If regular physical activity has been demonstrated to provide large health benefits [7][9] studies have reported that strenuous exercises and training of elite athletes could be associated with deleterious effects [10]: cardiac abnormalities [11], [12] more likely triggering a sudden death during high demanding effort [13], [14], with higher incidence rate among men varying according sports practice [15] and deregulated inflammatory responses [16]. In addition, training cessation after international career has showed to be deleterious in retired athletes [17][20]. Conversely, a recent meta-analysis of epidemiological studies has concluded that top-level athletes live longer than the general population [21].

Olympic Games (OG) are the highest competition level for rowing athletes; thus Olympians are exposed to the most extraneous training program and performance exigencies. This study aims to assess the overall mortality and main causes of deaths of male French Olympic rowers competing from 1912 up to 2012 compared with their referents in the French population.


Design and participants

Retrospective cohort study of French Olympic rowers. The cohort was composed of all male rowers who represented France in at least one OG, from 1912 up to 2012, and had their vital status validated by the National registry of Identification of Physical Persons (RNIPP). Coxswains were not accounted as rowers.

Three periods were taken into account to analyse rowers' overall mortality. The first (P1) included only rowers that participated in the OG from 1912 up to 1936. This period was chosen for a separated analysis because all rowers, who participated in those games, had already deceased, allowing for a complete follow-up until the entire cohort's extinction. The second period (P2) is an uninterrupted period of OG after World War II, from 1948 to 2012. Finally, we considered the total period (PT), analysing the totality of rowers participating in the OG from 1912 up to 2012 (Figure 1). The discontinuity at the rowers' entry in the cohort between 1912–1920 and 1936–1948 is related to the Games interruption due both World Wars.

Figure 1. French Olympic rowers by Olympic Games and birth year.

Black diamond represents deceased subjects and blue diamond represents the subjects alive at the study's endpoint. The two periods studied apart are schematically indicated.

Data collection

Data concerning rowers' biography came from historians' sources as previously reported [22]. These records were confirmed by data of the International Olympic Committee ( and the French Federation of Rowing ( Rowers' identity information and vital statuses were collected since their first Olympic participation up to January 1st 2013 (study's endpoint) from the RNIPP via INSEE (National Institute of Statistics and Economical Studies), which registers vital status of all French people since 1891. Hence, rowers born before 1891 were not included in the study.

The causes of death of each deceased subject were obtained from the CépiDc (Epidemiologic Centre on Medical Causes of Death). Currently, causes of deaths occurring on French territory are available via National registry from 1968 up to January 1st, 2012. Thus, only deaths occurring during this period were submitted to investigation of its causes.

This study was approved by the Advisory Committee on Information Processing in Research in the Field of Health (CCTIRS) and the French National Commission for Data Protection and Liberties (CNIL).

Statistical Analysis

We compared the mortality of French rowers with the French general population by calculating overall and disease-specific Standard Mortality Ratio (SMR) and its 95% confidence intervals (CI). SMR is the ratio between the number of deaths observed in the rowers' cohort and the number of expected deaths if the athletes had the same death rates of the French population with age and period adjustment [23]. The source for general population death rates was the French life tables available at the Human Mortality Database ( via CépiDc.

The number of expected deaths was therefore calculated by multiplying male French death rates by the rowers' person-years at the corresponding age and period. Person-years were computed so that each rower contributes for one record of each year during his follow-up.

The rowers' follow-up starts with their date of first OG participation and finishes with their date of death (if concerned) or with the study's endpoint. The rowers' entries in the cohort are represented in Figure 1.

The observed and expected survival estimations were illustrated by Kaplan-Meier curves [24] and were compared with use of the log-rank test.

For the disease-specific mortality we compared each cause of death found among rowers with the specific rate in the general population by calculating SMR's for the available identification period, 1968 to 2012. Causes of death were classified according to the International Classification of Diseases - ICD (8th revision before 1978, 9th revision between 1979 and 1999, 10th Revision after 2000).

The 95% confidence intervals were calculated using the exact method [25]. R software v2.14.0 was used for the analysis.


Overall mortality

A total of 255 male rowers represented France in the Olympics from 1912 up to 2012. All rowers verified by the RNIPP had their vital status validated, except for fifty-two (20.3%) who were not included in the study since they were born prior to 1891 (n = 10) or their date or place of birth were not properly validated (n = 42). Therefore, the analyses were performed on 203 French rowers.

Among rowers' cohort, 46 deaths occurred before the study's endpoint; 30 within P1 (Table 1). The age of death ranged from 35 to 100 years old. The mean age of death was 72.5 (±15.6) in P1 and 74.0 (±9.1) in P2. The PT overall mortality is significantly reduced by 42% compared with the French general population. Significant overall mortality reduction is also observed among rowers for both cohort periods considered apart (Table 1).

Table 1. French Olympic rowers' cohort description and their overall mortality compared with the French general population.

The rowers observed and expected survival curves are illustrated in Figure 2. The rowers observed curve is significantly different from the expected curve derived from the matched general French population (p = 0.008). The observed rowers' curve diverges and shifts to the right early in the follow-up period. The gap widens until 45 years of follow-up, and narrows afterwards until the end of follow-up. With increasing time, progressively fewer rowers contribute to the survival estimate.

Figure 2. French Olympic rowers' observed and expected survival curves.

Rowers' observed survival is represented by the solid black curve and its dashed confidence interval. The blue curve refers to the expected survival derived from the matched general French population.

Main causes of death

Among the 46 deaths observed, 36 occurred during the available period of death's cause identification (1968–2012). From those, 3 died abroad and their cause of death were not available. Therefore, 33 rowers had their underlying cause of death identified. The main causes of death (Table 2) observed were neoplasms, n = 11(33%), followed by cardiovascular diseases n = 7 (21%) and external causes n = 6 (18%). The ICD chapter of external cause comprises deaths related to accidents, homicides, suicides and falls. The remaining causes observed (nervous system diseases, genitourinary diseases, respiratory diseases, skin diseases and ill-defined conditions) together account for 27% of all causes of death identified. Concerning the three main causes observed among French Olympic rowers, cardiovascular diseases are 59% significantly lower than found in the general population. Neoplasms and external causes are not significantly different from the general population (Table 2).

Table 2. French Olympic rowers' main disease-specific mortality compared with the French general population.


To our knowledge the present study is the first to describe a survival advantage of elite rowers compared with their referents in the general population. The follow-up over the last century shows a 42% reduction of the overall mortality of French Olympic rowers. The early cohort of rowers (P1) followed until its complete extinction as well rowers competing post Wars up to 2012 (P2) showed a consistent mortality reduction.

The difference between observed and expected survival curves since the beginning of the follow-up illustrates the rowers' survival advantage over the general population. This advantage, visible since the beginning of the follow-up, increases with time and rowers deviate most from the expected when they are 50 to 70 years old. At older ages the rowers' survival approaches the curve of their compatriots.

The increased selectivity of the Olympics in the modern era may require increased training intensity and may further develop the use of enhancing performance techniques, with potential adverse effects on athletes' health [26]. The consequence of such period changes on elite rowers' mortality will only be fully acknowledged after the entire extinction of the current young rowers, as it will allow a complete retrospective analysis. Up to now, our results suggest that recent rowers' longevity (P2) follows the survival advantage trend observed among P1 rowers; the mortality difference with the general population even seems to widen. However our results should be cautiously interpreted as we compare healthy individuals at cohort's entry with the general population, including ill and handicapped individuals. This “healthy worker effect” [27] probably overestimates the mortality reduction found among rowers.

French rowers' survival advantage appears associated with a reduced mortality from cardiovascular diseases. The benefits of leisure endurance sports on the cardiovascular health are well known in the general population [28], [29] but some studies have underlined possible risks to the cardiovascular system due to excess training [13], [30], [31]. The preparation to OG includes important training volumes with rowers reaching more than 1000 h of training per year [32]. Such training loads undertaken during years of practicing produces major adaptations of the athletes' cardiovascular system [4], [33] a phenomenon probably enhanced by a previously selection process [34], [35]. Among French Olympic rowers, rather than a risk, the cardiovascular adaptation to training requirements to access the OG seems to be protective in light of the 59% mortality reduction found among them. Previous studies assessing cardiovascular diseases of endurance elite athletes as defined by the ICD show: a 51% reduction among Finish long distance running and cross country skiing [36] and a 37% reduction among French cyclists [37]. Finally, our findings among Olympic rowers are also in line with longevity studies assessing rowers from lower competitive level [5], [6].

Similar reduced overall mortality have been reported among other elite athletes cohorts [21], [36], [38], [39], including recent findings considering endurance athletes [40]. A study of French cyclists in the Tour de France with comparable methods - although the number of subjects and follow-up period are different - has shown a 41% reduction of cyclists overall mortality [37]. Although road cycling risks are greater than rowing [2], French rowers and cyclists presents similar mortality advantage over their compatriots. Yet, the lower injury incidence among rowers might be behind the contrast with American football players' mortality [41]. Despite an overall mortality reduction of 47% the players presented an increased mortality due to neurodegenerative diseases claimed to be related with concussive blows to the head.

We limited our cohort to Olympic athletes in order to focus on the highest sports level for which health consequences of intense training remains debatable [10]. Nevertheless, our results are based on a small absolute number of subjects, especially those concerning causes of death; hence they should be interpreted with caution. In addition, we are not able to determine how the excluded athletes might alter the magnitude of our findings. Finally, except for age and period, we could not adjust for potential confounding factors. Our methods advantage, however, relies on an extensive follow-up of French Olympic rowers followed during a century of OG, allowing for a complete follow-up of the rowers competing in the first Games. In addition, the vital status and causes of deaths assessed and validated by National sources reduces uncertainty.

Further investigations based on larger cohorts and in a large variety of countries are now needed to better apprehend elite athletes' reduced mortality. As it is out of an observational study's scope to determine causality, analytical studies are necessary to explain elite athletes' survival advantage. The assessment of lifestyle or physical activity post-career of elite athletes may provide better understanding of their mortality determinants.


French elite rowers followed-up during a century of Olympic Games benefit of lower overall mortality compared with the French general population. The cohort composed only of deceased rowers from the early Olympic Games analyzed apart and followed until its complete extinction shows also an important mortality reduction. Among elite rowers' main causes of death, cardiovascular diseases are reduced in relation to their compatriots. Analytical studies with larger samples controlling for confounders such as elite athletes' training-load and lifestyle after career are needed to understand the reasons behind elite athletes' survival advantage.


The authors thank the Institut National du Sport de l'Expertise et de la Performance (INSEP) for their full support.

All authors had full access to the data and were fully involved in the data analysis.

Author Contributions

Conceived and designed the experiments: JAJ FDD FD PLV JFT. Performed the experiments: JAJ AS AH. Analyzed the data: JAJ FDD FD JFT. Contributed reagents/materials/analysis tools: JAJ AS AH. Wrote the paper: JAJ FDD FD.


  1. 1. Brosh S, Jenner JR (1988) Injuries to rowers. Br J Sports Med 22: 169–169
  2. 2. Shephard RJ (1998) Science and medicine of rowing: A review. J Sports Sci 16: 603–620
  3. 3. Moorstein B (1968) Life expectancy of Ivy League rowing crews. JAMA 205: 106.
  4. 4. duManoir GR, Haykowsky MJ, Syrotuik DG, Taylor DA, Bell GJ (2007) The effect of high-intensity rowing and combined strength and endurance training on left ventricular systolic function and morphology. Int J Sports Med 28: 488–494
  5. 5. Hartley PHS, Llewellyn GF (1939) The longevity of oarsmen: A study of those who rowed in the Oxford and Cambridge boat race from 1829–1928. Br J Sports Med 1: 657–662.
  6. 6. Prout C (1972) Life expectancy of college oarsmen. JAMA 220: 1709–1711
  7. 7. Warburton DER, Nicol CW, Bredin SSD (2006) Health benefits of physical activity: the evidence. CMAJ Can Med Assoc J J Assoc Medicale Can 174: 801–809
  8. 8. Bize R, Johnson JA, Plotnikoff RC (2007) Physical activity level and health-related quality of life in the general adult population: a systematic review. Prev Med 45: 401–415
  9. 9. Sallis RE (2009) Exercise is medicine and physicians need to prescribe it!. Br J Sports Med 43: 3–4
  10. 10. Predel H-G (2014) Marathon run: cardiovascular adaptation and cardiovascular risk. Eur Heart J eht502
  11. 11. Gerche AL, Burns AT, Mooney DJ, Inder WJ, Taylor AJ, et al. (2011) Exercise-induced right ventricular dysfunction and structural remodeling in endurance athletes. Eur Heart J ehr397
  12. 12. Ector J, Ganame J, Merwe N van der, Adriaenssens B, Pison L, et al. (2007) Reduced right ventricular ejection fraction in endurance athletes presenting with ventricular arrhythmias: a quantitative angiographic assessment. Eur Heart J 28: 345–353
  13. 13. Drezner JA (2008) Contemporary approaches to the identification of athletes at risk for sudden cardiac death. Curr Opin Cardiol 23: 494–501
  14. 14. Marijon E, Tafflet M, Celermajer DS, Dumas F, Perier M-C, et al. (2011) Sports-related sudden death in the general population. Circulation 124: 672–681
  15. 15. Marijon E, Bougouin W, Périer M, Celermajer DS, Jouven X (2013) Incidence of sports-related sudden death in France by specific sports and sex. JAMA 310: 642–643
  16. 16. Cooper DM, Radom-Aizik S, Schwindt C, Zaldivar F Jr (2007) Dangerous exercise: lessons learned from dysregulated inflammatory responses to physical activity. J Appl Physiol Bethesda Md 1985 103: 700–709
  17. 17. Yoshiga CC, Higuchi M, Oka J (2002) Serum lipoprotein cholesterols in older oarsmen. Eur J Appl Physiol 87: 228–232
  18. 18. Petibois C, Cassaigne A, Gin H, Déléris G (2004) Lipid profile disorders induced by long-term cessation of physical activity in previously highly endurance-trained subjects. J Clin Endocrinol Metab 89: 3377–3384
  19. 19. Witkowski S, Spangenburg EE (2008) Reduced physical activity and the retired athlete: a dangerous combination? Br J Sports Med 42: 952–953
  20. 20. Marquet L, Brown M, Tafflet M, Nassif H, Mouraby R, et al. (2013) No effect of weight cycling on the post-career BMI of weight class elite athletes. BMC Public Health 13: 510
  21. 21. Garatachea N, Santos-Lozano A, Sanchis-Gomar F, Fiuza-Luces C, Pareja-Galeano H, et al. (2014) Elite Athletes Live Longer Than the General Population: A Meta-Analysis. Mayo Clin Proc 89: 1195–1200
  22. 22. Clarke PM, Walter SJ, Hayen A, Mallon WJ, Heijmans J, et al. (2012) Survival of the fittest: retrospective cohort study of the longevity of Olympic medallists in the modern era. BMJ 345: e8308.
  23. 23. Bernard P-M, Lapointe C (1987) Mesures Statistiques en Épidémiologie. PUQ. 329 p.
  24. 24. Pohar M, Stare J (2006) Relative survival analysis in R. Comput Methods Programs Biomed 81: 272–278
  25. 25. Liddell FD (1984) Simple exact analysis of the standardised mortality ratio. J Epidemiol Community Health 38: 85–88.
  26. 26. Deligiannis A, Björnstad H, Carre F, Heidbüchel H, Kouidi E, et al. (2006) ESC study group of sports cardiology position paper on adverse cardiovascular effects of doping in athletes. Eur J Cardiovasc Prev Rehabil Off J Eur Soc Cardiol Work Groups Epidemiol Prev Card Rehabil Exerc Physiol 13: 687–694
  27. 27. Last JM (1995) A Dictionary of Epidemiology. 3rd ed. Oxford, UK: Oxford University Press.
  28. 28. Schnohr P, Marott JL, Lange P, Jensen GB (2013) Longevity in male and female joggers: the Copenhagen City Heart Study. Am J Epidemiol 177: 683–689
  29. 29. Wang H, Dwyer-Lindgren L, Lofgren KT, Rajaratnam JK, Marcus JR, et al. (2012) Age-specific and sex-specific mortality in 187 countries, 1970–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380: 2071–2094
  30. 30. Möhlenkamp S, Lehmann N, Breuckmann F, Bröcker-Preuss M, Nassenstein K, et al. (2008) Running: the risk of coronary events. Prevalence and prognostic relevance of coronary atherosclerosis in marathon runners. Eur Heart J 29: 1903–1910
  31. 31. Mont L, Elosua R, Brugada J (2009) Endurance sport practice as a risk factor for atrial fibrillation and atrial flutter. Europace 11: 11–17
  32. 32. Fiskerstrand A, Seiler KS (2004) Training and performance characteristics among Norwegian international rowers 1970–2001. Scand J Med Sci Sports 14: 303–310
  33. 33. Pelliccia A, Kinoshita N, Pisicchio C, Quattrini F, Dipaolo FM, et al. (2010) Long-term clinical consequences of intense, uninterrupted endurance training in olympic athletes. J Am Coll Cardiol 55: 1619–1625
  34. 34. Kujala UM, Sarna S, Kaprio J, Tikkanen HO, Koskenvuo M (2000) Natural selection to sports, later physical activity habits, and coronary heart disease. Br J Sports Med 34: 445–449
  35. 35. Ruiz JR, Gómez-Gallego F, Santiago C, González-Freire M, Verde Z, et al. (2009) Is there an optimum endurance polygenic profile? J Physiol 587: 1527–1534
  36. 36. Sarna S, Sahi T, Koskenvuo M, Kaprio J (1993) Increased life expectancy of world class male athletes. Med Sci Sports Exerc 25: 237–244.
  37. 37. Marijon E, Tafflet M, Antero-Jacquemin J, Helou NE, Berthelot G, et al. (2013) Mortality of French participants in the Tour de France (1947–2012). Eur Heart J eht347
  38. 38. Gajewski AK, Poznańska A (2008) Mortality of top athletes, actors and clergy in Poland: 1924–2000 follow-up study of the long term effect of physical activity. Eur J Epidemiol 23: 335–340
  39. 39. Antero-Jacquemin Juliana, Latouche Aurélien, Toussaint Jean-François (2014) French Olympic Athletes Show a 50% Reduced Mortality Rate. Abstract: Volume 46: 5.
  40. 40. Ruiz JR, Fiuza-Luces C, Garatachea N, Lucia A (2014) Reduced Mortality in Former Elite Endurance Athletes. Int J Sports Physiol Perform
  41. 41. Lehman EJ, Hein MJ, Baron SL, Gersic CM (2012) Neurodegenerative causes of death among retired National Football League players. Neurology Available: Accessed 14 September 2014.